Results 151 to 160 of about 1,935,200 (187)

Dedicated drug-eluting stents versus bare-metal stents for vertebral artery origin stenosis: a real-world single-center experience. [PDF]

BMC Neurol
Sun X, Wang L, Zhu R, Zhang Y, Liu X, Zhang Z.   +5 more
europepmc   +1 more source

Drug-eluting stents from cardiology to pneumonology. [PDF]

Future Cardiol
Zarogoulidis P, Huang H, Freitag L.
europepmc   +1 more source

Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort. [PDF]

Am Heart J Plus
Jariwala P, Vallapuri GS, Konda BKR, Jangam SK.   +3 more
europepmc   +1 more source

Safety, efficacy, OCT-assessed vascular healing and angiographic outcomes of polymer-free versus biodegradable-polymer drug-eluting stents in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]

Eur J Med Res
Abouelenien MM, Mekky ME, Bakry Z, Sawafta Y.   +3 more
europepmc   +1 more source

Impact of Nonadherence to Any Antiplatelet Therapy After PCI With Drug-Eluting Stents on Critical Outcomes. [PDF]

JACC Asia
Mori Y, Friede T, Hattori S, Yamaji K, Fukuma S.   +4 more
europepmc   +1 more source

Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in Chronic Kidney Disease (CKD Dragon-Registry). [PDF]

PLoS One
Januszek R, Chamera M, Iwańczyk S, D'Ascenzo F, Kuźma Ł, Tomasiewicz B, Niezgoda P, Wolny R, Kowalewski M, Wybraniec M, Reczuch K, Dobrzycki S, De Filippo O, Pawlik A, Kasprzycki K, Skowron K, Bartuś S, Lesiak M, Gąsior M, Kubica J, Pawłowski T, Gil RJ, Waciński P, Bruno F, Cortese B, Wojakowski W, Wańha W.   +26 more
europepmc   +1 more source

Introducing and utilizing innovative technologies in health care systems: a country comparison for peripheral drug-eluting stents in Germany and the USA. [PDF]

Front Public Health
Felgner S, Eckhardt H, Dreger M, Panteli D, Henschke C.   +4 more
europepmc   +1 more source

Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial. [PDF]

BMC Med
Wang P, Zhou J, Gao H, Hu T, Sun D, Wang Q, Jiang H, Yin Z, Wen S, Jin Y, Chen H, Yuan M, Zhong L, Hu S, Lian Z, Jiang Z, Xia J, Liu J, Fu G, He X, Zhu B, Garg S, Onuma Y, Wang D, Serruys PW, Gao C, Tao L.   +26 more
europepmc   +1 more source

The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina. [PDF]

Glob Cardiol Sci Pract
Albadri Z, Almousali R, Abdulla S.
europepmc   +1 more source

One-Year Outcomes of Short-Term Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials. [PDF]

Catheter Cardiovasc Interv
Fretz T, Dasari S, Sakaleros J, Kayani AMA, Bluckner N, Pond K, Markus N, Cardona-Perez A, Garcia A, Lemus-Zamora R, Breall J.   +10 more
europepmc   +1 more source